Blogs

Announcement Scotland-related leading medtech company Seluna is encouraged to enhance the management and diagnosis of childhood sleep disorders, with the introduction of a crucial clinical validation study in collaboration with the Royal Hospital for Children in Glasgow, Scotland. With this upcom...

Announcement Amit Agarwal, the secretary of the Department of Pharmaceuticals, served to highlight India’s potential in precision and personalized medicines, excelling in a transition and leading the country to shape it into an innovative country. Following this, he continues to introduce b...

Announcement The pharmaceutical innovation and convergence of space discovery are paving the way for new opportunities, and Redwire Corporation is leading and ruling in this sector. Redwire received $25 million NASA single grant, the indefinite-delivery/indefinite-quantity (IDIQ) contract for on-...

Announcement At Taiwan Expo USA 2025 in Dallas, the intelligent healthcare pavilion proudly highlighted Taiwan’s emerging power in digital health innovation. The pavilion, organized by the Taiwan External Trade Development Council (TAITRA) and International Trade Administration (TITA) the p...

Announcement The Health Research Council of New Zealand invested NZ$4.6 million ($2.7 million) in the 10 new studies with the help of AI to enhance healthcare. It consists of projects to improve post-operative monitoring, extend community eye screening, and leverage radiology reporting. The fundi...

Announcement Royal Philips, a leading health technology company, will present its AI-enabled technologies, which are developed to enable deep insights in cardiac care and optimize clinical workflows at the European Society of Cardiology (ESC) 2025 congress in Madrid, effective from 209th August t...

Announcement The Korea Pharmaceutical and Bio-pharma Manufacturers Association (KPBMA) initiated the first practical training infrastructure for artificial intelligence (AI-related drug development in Korea. On the 29th of August, the AI drug convergence research institute marked a successful ful...

Announcement Considering the emerging health challenges and unexpected health disturbance in India, Tata AIA Life Insurance has introduced ‘Tata AIA Health Buddy’, India’s first-ever 24*7 health and wellness partner, providing life insurance, blending health and wellness. In Ind...

Announcement The Korean government has initiated a $16 million multimodal medical AI project across 14 private and public organizations. By far, 47 huge hospitals are in alliance with Korea’s EMR. Following this, South Koreans will have access to the medical records from the huge hospitals ...

Announcement The national innovation agency is in partnership with the Thai health tech trade association (Health Tech Startup Thailand) and collaborators in medical innovation districts worldwide, gathering brilliant entrepreneurs in the health and medical technology innovation based on medtech/...

Announcement Singapore’s Health Sciences Authority (HAS) and Malaysia’s Medical Device Authority (MDA) revealed a pilot program that will leverage access to class B, C, and D medical devices. The pilot program will start on 1st September onwards and will run through 28 February. The a...

According to Precedence Research, the global orthopedic braces and supports market size was accounted at USD 4.26 billion in 2024 and is expected to reach around USD 8.55 billion by 2034, expanding at a CAGR of 7.22% from 2025 to 2034 Orthopedic Braces and Supports Market Outlook The braces and ...

The American Heart Association Announced the RPM Program for Heart Failure Announcement The American Heart Association introduced an RPM (remote patient monitoring) program that enables cardiac care for heart failure patients at home after hospitalization. The American Heart Association Connecte...

Resilient Medical Corp made its Place in the Competitive Jumpstart Trailblazer Health-tech Accelerator Announcement The Resilient Medical Corp, the leading manufacturer and developer of an excellent implantable medical device that diminishes risk and seamlessly heals breast cancer patients, reta...

India and Taiwan Have a Chance to Boost their Health-tech Partnership Announcement Recently, Taiwan has been a topic of discussion in the healthcare industry, with a focus on medical innovation and wellness through its top initiatives, such as ‘Go healthy with Taiwan 2025’, which has...

Australian Health Tech Startup’s New AI Hack for Vets Announcement The Australian health tech startup Heidi Health has headed into the pet area to introduce and deliver its AI medical scribe across vet clinics and emergency animal hospitals. This is the best thoughtful health-tech idea rev...

According to Precedence Research, the global healthcare chatbots market size accounted for USD 1.49 billion in 2025 and is estimated to rise from USD 1.85 billion in 2026 to nearly USD 10.26 billion by 2034, growing at a double-digit CAGR of 23.92% from 2025 to 2034. This market is rising due to dig...

PDS Biotech’s Survival Data and Phase 2 Trial in Head and Neck Cancer Announcement The PDS biotechnology corporation, a leading late-stage immunotherapy company, aims to transform the ability of the immune system to kill and target cancers, proudly announced final excellent survival data f...

Varian Enrollment and Treatment Completion for Thoracic Bone Metastases Announcement Varian, a leading Siemens Healthineers company, completed enrollment and treatment in the FAST-02, a flash radiotherapy clinical trial for the treatment of symptomatic bone metastases in the thorax. The FAST-02 ...

AbbVie Prepared an Agreement to Acquire Gilgamesh Pharmaceuticals Announcement AbbVie and Gilgamesh Pharmaceuticals Inc. introduced their definitive agreement, claiming that AbbVie will acquire Gilgamesh’s popular investigational candidate, which is currently under clinical development for...

Drugmakers Fixing Technological Risks Pros and Cons of Adopting Technology in Healthcare Pharmas speed in adopting artificial intelligence is transforming manufacturing. Pharmas move to enhance the success rates, various variables led to the discovery of AI across the vast manufacturing chain, w...

Devonians Business Updates and Additional Details on the Last Declared Private Placement Announcement Devonian Health Group Inc., a leading clinical-stage corporation targeting the developing of different solutions for inflammatory disease, with the following corporate updates, including advance...

TME Pharma to Fund Via New Bond and Claim a New Notice of Shareholding Announcement TME pharma NV, a known clinical-stage biotechnology company pioneering in the development of therapies for eye disease and cancer, has stepped into fundraising of €500,000 to stabilize its financial capacity...

Sonic Acquired Cairo to Expand Hematology Oncology Testing Announcement Sonic Healthcare USA Inc has acquired all assets of Cairo Diagnostics LLC, Cairo Diagnostics NJ LLC, and Rye Management and Logistics Corp (its related to Cairo). Cairo is a reputable provider of inclusive hematology and onc...

Cambrexs New Manufacturing Destination in Waltham, Massachusetts Announcement Cambrex, a popular global contract development and manufacturing organization (CDMO), declared that Snapdragon chemistry cambrex company has extended its active pharmaceutical ingredient (API) facility in Waltham, Mass...

Roche Canada Received Market Authorization for a Drug Cpmbined with GemOx Announcement Hoffmann-La Roche Limited (Roche Canada) received a market authorization officially by Health Canada for Columvi (glofitamab for injection), in combination with gemcitabine and oxaliplatin (GemOx), suitable fo...

Malaysia’s Robust Healthcare Highlights in Cambodia Announcement The Malaysia Healthcare Travel Council (MHTC) introduced Malaysia Healthcare Week 2025 in Phnom Penh, Cambodia. The week is an effort highlighted to foster healthcare professional relations between the two nations and positio...

Thermo Fisher’s New Manufacturing Center in North Carolina Announcement The Thermo Fisher Scientific Inc., the global leader in delivering science, has opened its creative manufacturing center of brilliant facility in Mebane, N.C. The new site of carbon neutral is a 375,000 square foot fac...

Moffitt and PathAI’s Partnership to Initiate Digitalization Announcement PathAI, a known leader in digital pathology solutions and artificial intelligence, entered a multi-year partnership with Moffitt Cancer Center, one of the popular cancer hospitals and a global leader in cancer researc...

Invivyd Priced its Public Offering of Common Stock and Pre-funded Warrants in Millions Announcement Invivyd Inc. has revealed the pricing of an underwritten public offering of 74,811,404 shares of its common stock at a price of the offering by $0.52 per share for specific investors instead of co...

LinusBio’s ClearStrand-ASD has Entered Japan Announcement LinusBio, a popular player in precision exposome medicine, proudly declared that Clearstrand-ASD, its biochemical autism screening test, is available in Japan for research purposes via a partnership with YAC bio. This successful ste...

CORL Technologies and RiskRecon by Mastercard Entered into a Partnership for a Strong Purpose Announcement CORL Technologies, the leading healthcare company managing third-party risk management (TPRM) solutions, has entered a partnership with Mastercard.  The partnership will merge Masterca...

FDA Approved Rhythm’s sNDA Announcement Rhythm Pharmaceuticals Inc., a leading commercial-stage biopharmaceutical company aiming to change the lives of patients with rare neuroendocrine disease, has been given permission to file the supplemental new drug application (sNDA) for setmelanotid...

Pharmaceutical Sterile Sample Bags Market Driving Next-Gen Pharma Safety According to Towards Packaging, the global pharmaceutical sterile sample bags market size was estimated at USD 1.50 billion in 2024 and is anticipated to reach around USD 1.88 billion by 2034, growing at a CAGR of 2.27 ...

Aprecia and Battelle Partnered with the US Department of HHS and DARPA Announcement Aprecia and Battelle were granted a chance to collaborate with the US Defense Advanced Research Projects Agency (DARPA) as an award agreement to fuel the research program named ‘Establishing Qualification P...

Rady to Enter an International Partnership with Sidra Medicine Announcement Rady Children’s Institute for Genomic Medicine (RCIGM) entered into a collaboration with Sidra Medicine, an excellent specialty healthcare organization for women, young people, and children in the state of Qatar. T...

Biotechs Pursue a ‘Target Two Objectives With One Solution’ Strategy The History that Led to a Change in the Strategy From 2012 to 2020, AbbVie’s Humira, an excellent I and I, ranked as the most effective drug globally. The sales bar hit the growth level in 2022 in the times wh...

SkinMedica® Reveals its Secret Hydration Formula Announcement Allergan Aesthetics, an AbbVie company, revealed its new addition to its SkinMedica HA5 hydra collagen portfolio. Focusing on the brand’s exclusivity, HA5 hydra collagen complex, a mixture of five forms of hyaluronic acid an...

VerticalVet and Zomedica Entered a Collaborative Era Announcement Zomedica Corp., a veterinary health company providing therapeutic solutions and advanced diagnostics for equine and companion animals, has entered a partnership with Verticalvet, a reputable veterinary industry group purchasing or...

Opus Genetics Received FDA Approval for the IND Application Announcement Opus Genetics leading clinical-stage biopharmaceutical company initiating gene therapies for inherited retinal disease (IRD) treatment and small molecule therapies for different ophthalmic disorders, received FDA clearanc...

IQVIA and Veeva’s Global Commercial and Clinical Partnership and Clearance of Legal Disputes Announcement Veeva Systems and IQVIA entered a long-term commercial and clinical partnership and have completed settlement of all remaining legal issues. In this global agreement, the customers c...

Pharmacyte Biotech Signed a Securities Purchase Agreement with Existing Investors  Announcement Pharmacyte Biotech Inc. has signed a securities purchase agreement worth $7.0 million under financial terms with existing investors, engaging the sale of 7,000 shares of its newly positioned Se...

Subordinate of Dx&Vx Avixgen Entered a Licensing-out Agreement with a US Biotech Company  Announcement Avixgen, a secondary of Dx&Vx, declared on 18th August 2025 that it has entered a licensing out agreement at USD 360 million with a US biotechnology company to introduce a next-g...

Caris Life Sciences Proves its FDA-approved MI Cancer Seek® Announcement Caris Life Sciences, a global patient-oriented, promising AI techbio company, released a study in Oncotarget validating the clinical and analytical potential of MI Cancer Seek. This regulatory-approved assay is consi...

SpinaFX’s Device Received Approval as a Groundbreaking Device Designation by the US FDA Announcement The spinaFX Medical Inc., a known innovator in image-guided interventional spine care, has been positioned as a groundbreaking device designation for its main device, Triojection, by the ...

Ascentage’s Phase 3 Study of Lisaftoclax Announcement Ascentage Pharma, a leading marketizing level merger biopharmaceutical company involved in the development, exploration, and marketing of numerous different therapies to identify required medical needs in cancer, has received approval...

Valneva’s Chikungunya Vaccine Received Authorization in Canada Announcement Valneva SE, a specialized vaccine company, received marketing authorization from Health Canada for the single-dose vaccine IXCHIQ for serving prevention of disease related to the chikungunya virus for individual...

CIT and IFLI Partnered to Advance Cancer Therapies Announcement CIT Therapeutics Inc., a leading biotechnology company primarily aimed at accelerating next-generation small molecule therapeutics focusing on sumoylation for cancer treatment, has entered a partnership deal with the Institute for...

Vivani Medical Milestones and Update on Business Strategies, Released Financial Reports and Announced Equity Financing Business Updates Vivani Medical Inc., a leading biopharmaceutical company, updated its business plans. Vivani signed a share purchase agreement on 11 August 2025, to issue and...

Pilatus and Roche are Together in a Clinical Trial Collaboration Announcement Pilatus Biosciences Inc., a leading biopharmaceutical company leading in metabolic checkpoint immunotherapies for gastrointestinal and liver cancers entered into a clinical trial collaborative agreement with Roche. A...

Kodiak’s Business Status and Financial Reports Kodiak’s Recent Business Plans Kodiak Sciences Inc. showcased recent business highlights and financial results for the second quarter ending June 30, 2025. The tarcocimab phase 3 toplisted data is predicted to start in 1Q 2026 (6 month...

Siloam and AWS Cloud Entered a Partnership to Enhance Patient Care Announcement PT Siloam International Hospitals Tbk initially adopted cloud services involving initially from Amazon Web Services (AWS) to leverage AI-driven innovation and digital transformation in healthcare. With an almost n...

Medexus Wins this Quarter's Race with the Successful Debut of its New Drug Announcement Medexus Pharmaceuticals smartly achieved a modest revenue winner position in this quarter for its energized debut of its new drug GRAFAPEX. This new drug managed to recoup losses from generics eating into i...

Concentra, After a Steady 2024, is Back for Dealmaking with Many Biotech Firms Concentra Biosciences Comeback One of the busiest buyers of biotech has been suspicious. Concentra Biosciences, the popular biotech buyout operated by Tang Capital, has walked into a dealmaking after its slow and st...

Ocugen Closed the Registered Direct Offering at $20 Million Announcement Ocugen Inc., a leading biotechnology company in gene therapies for blindness diseases, closed its previously introduced registered direct offering regarding securities purchase agreement with Janus Henderson, a leading as...

Modular Medical’s Participation at the ADCES  Announcement Modular Medical Inc., a leading insulin delivery technology company with its first-ever FDA-approved patch pump introduced mainly to target all adult ‘almost-pumpers’ with its affordable and user-friendly aspect,...

Ocugen’s and Janus Securities' Purchase Agreement Announcement Ocugen Inc., a global biotechnology company in gene therapies for blindness diseases, signed a securities purchase agreement with Janus Henderson Investors, a leading asset management firm. Janus will purchase 20,000,000 sha...

Five Oral Obesity Candidates, a Competition to Lilly’s Orforglipron Lilly’s Orforglipron’ The Phase 3 data for Eli Lilly’s early oral GLP-1 therapy, orforglipron, were released last week. The addition of new advancements to the already advanced weight-loss space needs o...

Orchestra’s Rollout of the FDA-approved Protocol Update Announcement Orchestra Biomed Holdings, Inc., a leading biomedical company elevating excellent technologies to patients via risk-rewarded sharing partnerships, declared its official rollout of a US FDA protocol update. It has promin...

Fibrothelium and Vivolta Entered into a Manufacturing Contract Announcement Vivolta, a medical mechanism solution provider, entered a long-term contract with Fibrothelium, a pioneer in silk protein biomaterial. The partnership’s motive is to manufacture electro-driven components for use ...

Cognition’s Progressive Clinical Programs and Financial Results for the Second Quarter of 2025 Announcement Cognition Therapeutics Inc., a leading clinical-stage company producing advanced drugs for the treatment of neurodegenerative disorders, declared its financial results for the seco...

Trinity Officially Launched its FDA-approved Preeclampsia Testing Service Announcement Trinity Biotech plc, a leading commercial-stage biotechnology company targeting diabetes management solutions and human diagnostics, and wearable biosensors, has officially launched a new testing service for...

Reshape’s Shareholders Cleared the Required Approvals to Officialize the Merger with Vyome Announcement Reshape Lifesciences shareholders ticked all proposals required for the completion of the previously introduced alliance with Vyome Therapeutics. The partnership will be officially eff...

IAQ is a Game-changer in the Healthcare Market Challenges in Healthcare Most of the outpatient facilities and hospitals are under pressure to cut costs while enhancing patient outcomes. Most of the facilities still approach the outdated systems; the serious and overlooked factors are highlight...

The global lyophilized injectable drugs market size is anticipated to reach USD 1,330.78 billion by 2034, increasing from USD 397.17 billion in 2025. The market is expected to grow at a CAGR of 14.40% from 2025 to 2034. Global Outlook The global lyophilized injectable drugs market is evolving ra...

Ingersoll Rand to Rule Globally with its Life Sciences Portfolio Announcement Ingersoll has acquired Ireland-based Dave Barry Plastics, which is a long-experienced and skilled manufacturer of plastic products for healthcare companies and life sciences. The acquisition demonstrates the company'...

MannKind and Blackstone to Initiate a Financing Agreement Announcement MannKind Corporation is a pioneer in the development and commercialization of inhaled therapeutic products and device delivery systems for patients with endocrine and orphan lung diseases. MannKind’s funds are managed...

Cognizant’s New TriZetto® AI Announcement Cognizant introduced a new Trizetto AI gateway is a foundational product launched to easily merge generative AI capabilities into its Trizetto healthcare ecosystem. This is a new, excellent solution focused on evolving healthcare delivery by ...

Freenome’s Licensing Agreement with Exact Sciences to Introduce a New Test for Colorectal Cancer Announcement Freenome, a leading biotechnology company developing an early cancer detection platform, has entered a licensing agreement with Exact Sciences to elevate its marketization of its...

AI’s support to pharma companies to handle policy pressures Announcement The previous experience, spanning years and months, created a regulatory storm for the biopharma industry. Companies have largely obeyed executive orders this year. The tariff policies and the Inflation Reduction Ac...

Porosome’s findings discovered an advancement, transforming AD research and treatment Announcement Porosome Therapeutics introduced major advancements in its excellent disease-modifying neurological platform. The new advancement will transition alzheimer’s disease (AD) treatment and...

Ambulatory Neurosurgery Center and UB Neurosurgery Partnered with NOVA Neuro Announcement The neuroscience and neurotechnology universities at Buffalo Neurosurgery (UBNS) and ANSC received $144,500 award to launch worldwide’s first-ever multi-omics research initiative focusing on forecas...

Big Pharma, a New Fame and Hero to Chinese Companies By Changing Time and Circumstances The out-licensing of drugs to multinational corporations is a general initiative by Chinese biotechs, but the rising deals are only looking for ready biotech partnerships in the area. The multinational phar...

Cyagen and Taconic Partnered to Receive Permission for Preclinical Studies of Mouse and Rat Models Announcement Cyagen Biosciences, a leading AI-powered CRO company, a pioneer in cell models for research, and custom genetically engineered animals, collaborated with Taconic Biosciences, a well-...

Noom’s New Microdose GLP-1 Program Aims to Tackle Obesity Announcement The Noom, a well-established digital healthcare company focused on chronic disease prevention and encouraging people to live a quality and longer life, launched the Noom microdose GLP-1program, a commendable initiati...

Solving the Commercial Puzzle to Succeed in Cell and Gene Therapies This Year's Challenges to CGT This year witnessed two leading examples of the challenges faced by the cell and gene therapy space, named Bluebird Bio and Sarepta Therapeutics. The two leaders, despite having products on the ma...

Fresenius and Polpharma Entered a Licensing Contract for the Proposed Vedolizumab Biosimilar PB016 Announcement Polpharma Biologics SA, a leading biotechnology company, signed a licensing agreement with Fresenius Kabi for marketing PB016 worldwide except North Africa and the Middle East. PB016...

Kuros Biosciences' New MagnetOs MIS Delivery System Announcement Kuros Biosciences, a known innovator of biologic technologies, completed its first-ever US international case with its new magnetos MIS delivery system. A system features, prefilled, sterile, and single-use delivery system helpfu...

LOTTE BIOLOGICS Bolstered its CDMO Expansion in North America and Asia Announcement Lotte Biologics’ CEO James Park is leveraging its growth as a global Contract development and manufacturing organization (CDMO) company. This year, the company has elevated its CDMO business expansion wit...

Glioblastoma Funding Skyrockets as this Condition Raises Concern Among Nonprofits Announcement According to research, glioblastoma is a life-threatening brain cancer that is difficult to treat. The recent acquisitions by Merck and Jazz Pharmaceuticals, along with the development of innovative ...

New Disease Suspected in Ovarian Cancer Patients Announcement The overall survival (OS) rate for advanced ovarian cancer has consistently been stagnant for almost four decades, because of its steady recurring process. Though patients react safely to the initial chemotherapy and surgeries, it h...

Demetra to Launch a New Global Spine Division by Acquiring Orthofundamentals LLC Announcement Demetra, a well-established and innovative international medical company, and a leader in spacers, biomaterials, and bone cements for PJI infection control and orthopedic applications, has acquired Or...

Mabwell Received a Green Signal for CDH17 Announcement Manwell, an innovative and leading biopharmaceutical company, the pioneer of the entire industry chain, declared that its proprietary CDH17-focused antibody-drug conjugate (ADC), 7MW4911, has received an acceptance from china’s natio...

Genvira and NRC were Highlighted for their Collaborative Project Announcement Genvira Biosciences Inc., a pioneering Canadian innovator in viral vectors, LabSkin Limited, a global leader in 3D in vitro human skin models, and the National Research Council of Canada (NRC) will be introducing a c...

Silexion’s Robust Preclinical Data Dhowed Excellent Results Announcement Silexion Therapeutics Corp., a global clinical-stage biotechnology company developing RNA interference (RNAi) therapies for KRAS-targeted cancers, revealed excellent new preclinical data results, stating the inhibit...

Zenara’s Final Approval for its New Capsules Announcement Zenara Pharma Private Limited, a pioneering biophore company, finally received approval from the FDA for its abbreviated new drug application (ANDA) named Sertraline Hydrochloride Capsules (SHC), 150 mg and 200 mg. It is the first...

Azenta and Frenova’s Partnership to Advance Genomic Research in Nephrology Announcement Frenova, a division of Fresenius Nephronomics and Medical Care, a renal precision medicine company, and Azenta Inc. entered into a partnership to head start with data generation for Frenova’s tr...

According to Precedence Research, the global in-vitro inflammatory bowel disease diagnostics market size is expected to be worth around USD 3.02 billion in 2034, increasing from USD 1.84 billion in 2025. The market is poised to grow at a CAGR of 4.9% from 2025 to 2034. In-Vitro Inflammatory Bowel...

Alafair BioSceinces Received Confirmation for Versacoat™ Nerve Protector and Versacoat™ Tendon Protector Announcement Alafair Biosciences, a well-established medical device company reshaping soft-tissue protection in orthopedic surgery, received a 510 (k) clearance from the FDA for...

Moderna’s Updated COVID-19 Vaccine Received Approval from the European Commission Announcement Moderna Inc. received a commercial authorization from the European Commission on the updated formulation of the COVID-19 vaccine known as Spikevax, focusing on the SARS-CoV-2 variant Lp 8.1 for...

W Health Ventures Funded Millions to Develop Healthcare Innovation in India Announcement W Health Ventures has raised a $70 million fund for the second time to help healthcare startups build from scratch. This valuable initiative reflects the firm’s commitment to the next-generation of h...

Xenetic and Periness Signed a ‘Clinical Study Agreement’ Announcement Xenetic Biosciences Inc., a leading biopharmaceutical company focused on developing and advancing innovative immune-oncology technologies, identifying treatments for cancer patients, partnered with Periness Ltd. ...

Natera Introduces ABCSG 61’s TEODOR Trial Announcement Natera Inc., a well-known leader in cell-free DNA and precision medicine, has begun a new TEODOR trial, a neoadjuvant treatment optimization featured by ctDNA and endocrine responsiveness. The TEODOR is a phase 2 multicenter, randomi...

Four Biotech Companies Standing Strong Against Market Waves A Drug Struggles Through Clinical Trials A drug typically takes around 10 to 15 years to undergo clinical trials, and after completing them, it reaches the final step of approval. There are more big tests on the way in the market spec...

Benecard and DecisionRX Formed a Partnership to Enhance Pharmacy Benefits Announcement DecisionRX, Inc., a key player in medication therapy optimization (MTO), and Benecard PBF, the original pharmacy benefit facilitator (PBF), entered into a strategic partnership initiated to introduce persona...

Kedrion’s COAGADEX® Received Confirmation of ‘Orphan Drug Designation' Announcement Kedrion Biopharma’s COAGADEX is now declared an orphan drug designation from the US Food and Drug Administration (FDA). The coagulation factor X human (tradename COAGADEX) will be a treatm...

Genethon's New Trial in Europe for Duchenne Muscular Dystrophy Announcement Genethon, a global prominent leader in research and development in gene therapy for rare genetic diseases, received approval from regulatory authorities, EMA and MHRA, for crucial phase 3 clinical trials in the UK and ...

Bristol and Bain Capital’s New Company Announcement Bristol-Myers Squibb and Bain Capital together have built a new independent biopharmaceutical company. A company that will be aiming the develop new treatments for autoimmune diseases that address the prominent needs of patients. The ne...

Pahr Therapeutics Raises Funds to Contribute to Pulmonary Arterial Hypertension Announcement Pahr Therapeutics Inc. was financed with $14M, along with AN Venture partners, University of Tokyo Edge Capital Partners (UTEC), and RA Capital Management. The company tends to develop therapies for pu...

Virocell and Avencell Partnered to Elevate Development in Treatments Announcement Virocell biologics, a popular vector contract development and manufacturing organization (CDMO) for cell and gene therapy (CGT) clinical trials, entered a partnership with Avencell Therapeutics Inc., a global cli...

Spear Bio’s New Solution to Modify Neurodegenerative Disease Research Announcement Spear Bio, a leading biotechnology company evolving homogeneous ultrasensitive immunoassay technology, has now commercially introduced SPEAR Ultradetect™ immunoassay solution. The new solution provid...

The Rising Alzheimer's Disease has Led Biopharma to Enter a Holistic Treatment Era The start to look up for In the last two years, 2023 and 2024, the treatment for the first-ever disease, Alzheimer's, received approval, which was introduced by Eisai and Biogen (for Leqembi) and Eli Lilly&rsquo...

GSK and Hengrui Pharma’s Collaboration for Drug Development Announcement Hengrui Pharma signed an agreement with GSK plc to develop 12 innovative medicines in addition to Hengrui’s primary value to the effective globalized strategy and GSK's new growth opportunities through 2031. T...

The New FDA Vouchers and Drug Pricing Confusion, a New Chaos in the Biopharma Sector FDA’s New Voucher Program or Confusion The commissioner's national priority vouchers focus on providing elevated pathways for drugs similar to few criteria, including a low price tag. This policy was exp...

USCDI’s Latest Version Aims to Improve Treatments Announcement The Assistant Secretary for Technology Policy (ASTP) announced the latest version of United States Core Data for Interoperability (USCDI) on July 24, 2025. USCDI is also globally known as USCDI v6. The office of the national ...

Lilly and Gate Bioscience Partnered to Advance Molecular Gate Medicines Announcement Gate Bioscience, a leading biotechnology company advancing molecular gates, a new class of small molecule drugs to discard disease-related proteins at their source, has signed a license agreement and partnered...

Plug and Play New Healthcare Program in Orlando Announcement Plug and Play, a global innovation platform, will be launching a healthcare program in Orlando, Florida. Under the partnership with Orlando Health, KPMG LLP, and Guidewell, the program will be inviting around 10 to 12 startups in its...

Washington University in St Louis and MilliporeSigma Appeared Together to Bolster Scientific Collaboration Announcement The Milliporesigma, the Canadian life science and the US business of Merck KGaA, Darmstadt, Germany, a popular technology and science company, entered into a contract, signin...

Xenetic Biosciences to Extend R&D Agreement with the Scripps Research Institute Announcement Xenetic Biosciences Inc., a leading biopharmaceutical company popularly known for its innovative immune-oncology technologies to identify difficult oncology indications, has extended its collaborativ...

Global RDH12 Alliance and Opus Genetics Entered a Partnership Agreement Announcement Global RDH12 alliance and Opus Genetics Inc., a biopharmaceutical company accelerating gene therapies for the treatment of small-molecule therapies and inherited retinal disease (IRDs) for other ophthalmic disor...

Tharimmune’s Common Stocks and Warrants are Now Available for Purchase Announcement Tharimmune Inc. (Tharimmune and the company), a biotechnological company, a leader for therapies in inflammation and immunology, has revealed the price of its registered direct public offering with a few pu...

Caravan Biologix Received a Research License for the KOMbine™ Platform Announcement KOMO Biosciences, a known precision genome engineering offered a research license to Caravan Biologix, a commendable innovator in advancing mini-CAR technology, and a miniature T-cell that holds the natural...

Kansai and Alloy are in a Collaboration to Leverage Growth in Japan Announcement Kansai Startup Academia Coalition, represented by Kyoto University, fostered to expansion university university-affiliated life science startups throughout Japan, and Alloy Therapeutics co, Ltd. has signed a memoran...

QIAGEN Enhances its Portfolio with Long-read Panels Announcement Qiagen has introduced new QIAseq xHYB long-read panels, a groundbreaking solution designed to explore the long-read sequencing of genomically complex regions. This sequencing idea strongly builds Qiagen’s position as a provid...

Hengrui and IDEAYA Bioscience’s Publication for a Presentation at IASLC 2025 Announcement Jiangsu Hengrui Pharmaceuticals co ltd a pharmaceutical company known for its technological and scientific innovation, and IDEAYA Biosciences Inc., a global precision medicine oncology company, showca...

AAVnerGene and Klotho’s Alliance Announcement AVVnerGene Inc., a Rockville, MD innovation-fueled biotech known for its remarkable technologies in AAV tissue-targeted delivery and manufacturing, and Klotho Neurosciences Inc. have entered a partnership to enhance the product’s potentia...

Cycle and Handa Signed an Exclusive Sales License Agreement Announcement Cycle Pharmaceuticals signed a us commercialization (sales) agreement with Handa Therapeutics LLC for PHYRAGO distribution (availability). The PHYRAGO is an FDA-approved drug for the treatment of the two types of leukemia, ...

Sarepta Therapeutics Pauses ELEVIDYS Shipments in the US to Play a Vital Role Announcement Sarepta Therapeutics, Inc., a known producer of precision genetic medicine for rare diseases, decided to temporarily and voluntarily halt all shipments in the United States for Elevidys (delandistrogene mo...

AstraZeneca Intends to Invest in America Announcement AstraZeneca plans to invest approximately $50 billion in the United States by around 2030 to manufacture medicines and boost its research and development efforts. The investment will unlock skilled indirect or direct jobs across the region th...

AusperBio Phase 3 Clinical Trial Approved by CDE Announcement Ausperbio Therapeutics Inc. and Ausper Biopharma Co., Ltd (merged Ausperbio), a biotechnology company known for the advancement in oligonucleotide therapies for chronic hepatitis B (CHB) functional cure, received approval to perform a...

NKGen Biotech and HekaBio Came Together to Bring New NK Cell Therapy to Japan Announcement NKGen Biotech, a US-headquartered clinical-stage biotechnology company with a strong focus on the development and commercialization of novel autologous and allogenic natural killer (NK) cell therapies, ann...

Korea’s CoresteamChemo & ATG Lifetech came Together to Expand the CRO’s Global Reach Partnership Overview A South Korea-based, leading GLP-certified preclinical CRO, CoresteamChemo, and a biotechnology company specialized in transcriptome analytics and organoid-based modeling, AT...

Rossari Biotech’s Q1 PAT Slides by 4% YoY to RS 34cr About Rossari Biotech Rossari Biotech is a specialty chemical manufacturer based in Mumbai, India, that provides intelligent and sustainable solutions for industrial consumers. Rossario Biotech operates manufacturing facilities, which ar...

SAPU Bioscience's Comprehensive Data Analysis Highlights Sapu Biosciences, LLC, a fully owned subsidiary of GMP Biotechnology Limited (GMP Bio), in partnership with Oncotelic Therapeutics, Inc., a biopharmaceutical company unlocking new stages of small molecule and RNA-targeted therapeutics for ...

Lisata and WARPNINE Cleared One Stage of their ILSTA trial in Australia Announcement The warpnine incorporated, Western Australia’s non-profit clinical research organization for rare, pancreatic, and gastrointestinal cancers, and Lisata Therapeutics Inc., a pharmaceutical company popular f...

10X Genomics and A*Star Genome Institute of Singapore Advance with a Breakthrough Announcement The 10x Genomics Inc., a captain of spatial biology and single-cell, and the A*STAR Genome Institute of Singapore have initiated a research collaboration, focusing on inference from integrated spatialo...

Tulane University and 60 Degrees Entered into a Research Agreement Announcement Leading pharmaceutical company, 60 degrees pharmaceuticals, known for its sharp focus on the development of new medicines for infectious diseases, has signed a research agreement with Tulane University to monitor the...

Sarepta's Strategic Plans and Upgradation in the ELEVIDYS Label Sarepta Therapeutics Inc., after achieving major milestones in the precision genetic medicine for rare diseases, is now planning to elevate its business by reshaping its strategic plans that will be fueling programs to achieve 2027...

Nature Medicine’s Results are Out Announcement Innovent Biologics, Inc., a biopharmaceutical company that manufactures, commercializes, and develops medicines for the treatment of oncology, metabolic, ophthalmology, autoimmune, cardiovascular, and other severe diseases, confirmed that th...

Amphix Bio's New Milestone in the Treatment of Acute Spinal Cord Injury Amphix Bio, a pre-clinical company that is building a new therapeutic modality for regenerative medicine, has received orphan drug designation for AMFX-200, a treatment for acute spinal cord injury (SCI). SCI is an extreme ...

ASAP and the Allen Institute Gathered to Discover Insights into Parkinson's and Other Diseases Announcement The Allen Institute and the Aligning Science Across Parkinson’s 9asap initiative are gathering to explore insights into neurodegenerative-related disease and Parkinson's with its...

MilliporeSigma’s AAW™ Workstation Announcement The Canadian and US life science business, MilliporeSigma of Darmstadt, Merck KGaA, and Germany, as a global science and technology company, has introduced the AAW automated assay workstation. It is a solution for Opentrons. Opentrons ...

Lily’s New Formulation for Active CD Received Approval Announcement Eli Lily Canada Inc. received approval from Health Canada for Omvoh® (mirikizumab) for CD. It will be available soon for Canadian patients. This drug is an interleukin-23p19 antagonist used for the treatment of adult...

Time to Appreciate Women-led Biotech: Know More About the Leaders in Biotech Industry Accomplishment Last year's record shows that most of the standard acquisitions consist of women-led biotech valuable contributions to the biotech’s growth. The biopharma is strengthened and positioned h...

Akeso Enrolled First Patient for MCRc Akeso Inc. has enrolled its first patient in the registration phase 3 clinical trial AK112-312/HARMONi-GI6 of ivonescimab for its primary treatment of advanced metastatic colorectal cancer (mCRC). The phase 3 trial is a center for the company to achieve pri...

Kraig’s New Addition to the Healthcare Market Announcement Kraig Biocraft Laboratories Inc., a global leader in spider silk technology, has initiated a second parallel production facility, the quick introduction of a new diapausing system, and three new advanced spider silk strains for p...

The ViiV’s Study Indicates the Importance of Choosing Suitable Drugs Announcement ViiV Healthcare, the expert specialist HIV company majorly owned by GSK, along with Shionogi and Pfizer as shareholders, introduced data from its phase 3b volition study, which elaborates that around 89% (n...

Zimmer Biomet to Acquire Monogram Technologies Announcement Zimmer Biomet Holdings, Inc. a popular medical technology and Monogram Technologies, a known orthopedic robotics company, have signed an agreement to acquire outstanding shares of stock of monogram to receive an upfront payment of $4....

Acadia’s R&D Day and Upgradation New Products and Strong R&D Acadia Pharmaceuticals, in its 32 years of business and has currently organized its first R&D day, predicting annual sales of around $12 billion from its investigational chain. Daybue for Rett syndrome and Nuplazid ...

CEL-SCI’s Agreement Approach to a Saudi Arabian Pharma Company Announcement The CEL-SCI corporation (NYSE American CVM) has approached an agreement with a known Saudi Arabian premier healthcare and pharmaceutical company for a strategic partnership that includes commercial and regulatory a...

Nutcracker and Elegen’s Pilot Program Announcement The nutcracker therapeutics a RNA design and manufacturer and Elegen, a DNA manufacturer are introducing a pilot program to describe the company’s first ever full synthetic, cell-free manufacturing platform for RNA-powered personaliz...

‘Weight loss medication’ a New Trend in the Healthcare Market Announcement At the American Diabetes Association’s annual meeting, the need for new weight-loss medicines, primarily for muscle preservation and showing fewer side effects, was the center of concern. The topic enter...

Adopting Precision Diagnostics to Shape the Future of Oncology Therapies A Step Towards the Future of Advanced Therapies The AI-based analysis and digital imaging are believed to be advanced precision oncology therapies for the next generation to achieve potential and access to all patients. The...

Pfizer and Astellas' Positive Results Mark a Significant Improvement Image Credits: The Astellas US Newsroom Announcement Pfizer Inc. and Astellas Pharma Inc. proved their potential with the positive results directly from the overall survival (OS) analysis from its phase 3 study of EMBARK. A st...

Max Healthcare is Set to Flourish in the Healthcare Industry Image Credits: The Financial Express Efforts The hospital chain is expanding and focusing on growth in the Delhi-NCR region. The region is experiencing excellent growth in margins and ARPOB, and occupancy, which reflects the early day...

Novartis and Pan-Canadian’s Partnership has Finalized Negotiations Announcement Novartis Pharmaceuticals Canada Inc. finally confirms its partnership with Pan-Canadian Pharmaceutical by settling down with an effective negotiation on (Pcpa) public reimbursement of Cosentyx (secukinumab) for...

Pelthos Introduces New Medicine in the Healthcare Market Image Credits: eMPR Announcement Ligand Pharmaceuticals Incorporated partner Pelthos Therapeutics Inc has commercially introduced ZELSUVMI (berdazimer) topical gel 10.3%, which is an FDA-approved (at-home treatment) for molluscum contagio...

Connect Biopharma’s Partner Company to Submit its New Drug Application Announcement Connect Biopharma Holdings Limited, a biopharmaceutical company known for its unique care for the treatment of inflammatory disease, has proudly announced that its partner company, and a China-licensed comp...

Inventiva Announced a New Member for the Company Image Credits: The Pharma Letter Announcement Inventiva, a biopharmaceutical company known for the development of oral therapies mainly for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), is happy to experience a transit...

Biocytogen and BeOne Medicines’ Licensing Agreement Image Credits: Biocytogen Announcement Biocytogen [Pharmaceuticals Co., Ltd., a leading biotechnology company that excels in research and development of antibody-based drugs with its innovative technologies] has signed a licensing agreem...

The Proposed Public Offering of Rhythm’s Image Credits: AInvest Announcement Rhythm Pharmaceuticals Inc., a commercial-based biopharmaceutical company, has nearly improved the lives of rare neuroendocrine patients and has released the proposed public offering of $150 million of its common...

BioNxt Solutions' Overview of New Advancements in the Healthcare Market Image Credits: Irish Sun Announcement BioNxt Solutions Inc., a biopharmaceutical company known for its advanced drug-delivery technologies, has introduced a new advancement in the potential development, focusing on the chem...

Quanterix closed the acquisition of Akoya Biosciences Image Credits: BioPharma APAC Announcement Quanterix Corporation, a leading company with its core scientific discovery via an ultra-sensitive biomarker identifier, has completed its previous acquisition of Akoya Biosciences Inc., a leader in...

Six Biotech Companies’ Initiative to Shape the Evergreen Age Image Credits: Faster Capital Announcement The modern era, which is experiencing and adopting computational techniques and deep biological knowledge, expects a change in rejuvenating the concerned area, as aging has been a core ...

Cardio Diagnostics Partnered with AGEPHA Pharma Image Credits: Caristo Announcement Cardio Diagnostics Holdings Inc., a leading cardiovascular medicine company, along with its advanced technology related to AI and intersecting epigenetics, has signed an agreement with AGEPHA Pharma. The agreeme...

Invivoscribe’s Support to CERo Therapeutics Image: News Hub Medianet Announcement Invivoscribe Inc., a leader in measurable residual disease (MRD) testing and accurate diagnostics, is joining hands with and appreciating CERo Therapeutics Holdings Inc.’s approach to innovative immuno...

Belay Diagnostics Evaluation Received the Green Signal Image Credits: Nature Announcement Belay Diagnostics, a CAP/CLIA Laboratory known for its commercialization and development of molecular diagnostics, mainly focusing on central nervous system (CNS) cancers, has confirmed the analytical vali...

Chugai and Gero Signed a License and Joint Research Agreement Image Credits: BioPharma BoardRoom Announcement Chugia Pharmaceutical Co., Ltd. and Gero PTE.LTD both a Singapore-based biotechnology company, has signed a licensed and joint research agreement to develop and introduce therapies for ...

Celltrion’s New Launch of Medication in the US Image Credits: Chosunbiz Announcement Celltrion USA confirmed that OSENVELT (denosumab-bmwo) and STOBOCLO (denosumab-bmwo), references to XGEVA and PROLIA, are available in the US. Access to these medications will improve and enhance patient ...

AI and Genetics: A New Hope for Pharma Companies Image Credits: Allerin Current Situation The pharmaceutical industry is facing difficulties in gaining the public's trust. The drug reactions often cause adverse effects to health and are not suitable for every individual. The advancement and dev...

Nasal COVID-19 Vaccine Demonstrates Positive Results in Phase 1 Clinical Trial Image Credits: NBC News Findings During the extreme stage of the COVID-19 pandemic, scientists noted that the complications of this infection started to increase severely with the SARS-CoV-2 virus entering the nasal ...

Onco-Innovations and Nucro-techniques Partnership to Elevate Human Trials Image Credits: WIVB Announcement Onco-Innovations Limited has signed an agreement with Nucro-technics Inc. on 3rd July 2025. Through this agreement, Nucro-Technics will organize a vast range of preclinical studies contrib...

Drug Development and Real-world Clinical Needs Establish a New Era in Oncology Image Credits: MEDSIR Concern The United States, till now, has completed 321.4% of phase 2/3 clinical trials. The percentage is less than compared of other regions' clinical trials. The patient recruitment and protoc...

Fresenius Medical Care and CCINSHAE's Strategic Collaboration to Expand Innovative Therapy Image Credits: Fresenius Medical Care Announcement Fresenius Medical Care, a global provider of products and services for patients suffering from renal diseases, will expand high-volume hemodiafiltration ...

Innocare’s Received Approval for a Clinical Trial in China Image Credits: BioWorld Announcement Innocare Pharma, a global biopharmaceutical company known for its advanced treatment for autoimmune diseases and cancer, received approval of an IND Investigational New Drug by the CDE Center f...

Brii Biosciences Signed a Licensing Agreement with Joincare Group Image Credits: Vietnam Investment Review Announcement Brii Biosciences, a global biotechnology company known for its excellent therapies for various diseases, has signed a technology transfer and license agreement with Joincare P...

Monte Rosa’s Solution in the Research Article Image Credits: Monte Rosa Therapeutics Inc. Publication Monte Rosa Therapeutics Inc., a global biotechnology company that has discovered molecular glue degrader (MGD) based medicines, introduced discoveries via a research article, featured on ...

Japan’s 3D Bioprinted Human Tissu e Market is Seeking Growth by 2025-2032 Current Status Japan’s 3D Bioprinted Human Tissue Market is concentrating on opportunities and growth in the coming years. The mid-year is focusing on innovation, development, and new engagement in this market t...

SurgiBox Partnered with Ondatec   Medical Announcement SurgiBox Inc., a leading medical technology company known for its excellent surgical services, has entered into a partnership agreement with Ondatec Medical, a popular medical device provider in Turkey. This partnership strongly ref...

Pelthos Therapeutics Finalized the Merger Agreement with Channel Therapeutics Announcement Pelthos Therapeutics Inc., a global biopharmaceutical company known for marketing innovative therapeutic products for patients in need, is wrapping up the previous merger agreement with CHRO Merger Sub Inc...

Lixte Biotechnology Holdings Inc.'s Finalization of Securities in the Market Announcement Lixte Biotechnology Holdings, Inc., a pharmaceutical company, closed its private placement with valuable investors for the sale and purchase of $5.0 million of shares of common stock, a series B convertible...

Bluebird, a Center of Attraction What makes a popular equity firm approach a small biopharma firm? The Carlyle Group, along with SK Capital partner, intends to buy bluebird Bio for under $50 million. The Carlyle Group, with its $453 billion in assets under management, and SK Capital partner of $...

Which Company is Investing in Improving a Specific Treatment? Kardium Inc., a founder of the ‘Globe® Pulsed field system’, which is an innovative treatment for atrial fibrillation (AF), has increased its investment to US$250 million. The financing round consists of new investors s...

Gilead's Chances Peak Until GSK’s Response to the Competition Announcement Gilead’s new PreP drug, ‘Yeztugo’, is said to be reaching sales of $4.5 billion, if GSK doesn’t have anything to say about its Apretude medication. Gilead is strengthening its position in the...

BioVersys and Shionogi Joined Forces to Accelerate Research and Development Announcement BioVersys AG, a biopharmaceutical company known for its excellent research and development of antibacterial products for severe infections caused by multidrug-resistant (MDR) bacteria, has signed an exclusiv...

Rinri’s Clinical Trial Application, a First Approval of the Month Image Credits: Hearing Health & Technology Matters Announcement Rinri Therapeutics, a global company aiming to bring a transformation and development in sensorineural hearing loss (SNHL) with regenerative cell therapy, ...

Another Innovation to be Launched at ENDO 2025 Image Credits: The Manila Times Announcement Crinetics Pharmaceuticals, Inc. is ready to showcase eight abstracts from its clinical development programs, and its oral presentations involve an investigational drug candidate, atumelnant, and PALSONIF...

MaxCyte ExPERT Platform in Japan Image Credits: Galveston Country Daily News Announcement The PHC corporation, a biomedical division subsidiary of PHC Holdings Corporation, has entered an agreement with MaxCyte Inc. for the distribution of the MaxCyte ExPERT platform in Japan. In June, Singapor...

A Clinical Collaboration to Fuel the Healthcare Market Image Credits: Seeking Alpha Announcement Summit Therapeutics Inc., a biopharmaceutical oncology company, and Revolution Medicines Inc., a leading clinical oncology company, have entered into a clinical collaboration. Revolution medicines m...

HUTCHMED Received Approval from China Image Credits: Sharecast Announcement HUTCHMED (China) Limited has received approval from the China National Medical Products Administration (NMPA) for its new drug application merging TAGRISSO® (osimertinib) and ORPATHYS® (savolitinib). The approva...

Riliprubart Received Orphan Drug Designation in Japan Image Credits: Western Slope Now Announcement The Japanese Ministry of Health, Labour and Welfare appointed riliprubart as an orphan drug designation. Riliprubart is a monoclonal antibody suppressing active C1s in the classical complement fo...

ESTEVE’s Agreement with Sanofi Image Credits: AInvest Announcement ESTEVE signed an agreement with Sanofi, a French multinational pharmaceutical and health-care company, to acquire Caprelsa® (vandetanib) rights in over 50 countries and more. It’s a treatment that applies to chil...

June Wrap-up with Approvals Image Credits: Biospace Approvals The FDA recently granted approvals for UroGen and RSV immunization. With the approval, Moderna expands mRNA RSV shot. On 13th June 2025, the FDA confirmed Moderna’s mRNA vaccine, mResvia, for respiratory syncytial virus, a solu...

Orphalan Partners to Donate and Ensure Access to all Communities Image Credits: Wilson Disease Org Announcement Orphalan SA, a pharmaceutical company targeting rare diseases, announced its partnership with MAP International and the Wilson Disease Association (WDA). This alliance will enable acc...

FUJIFILM VisualSonics’ Smart Patform for Preclinical Ultrasound Image Credits: Imaging Technology News Announcement FUJIFILM VisualSonics Inc., popular in photoacoustic imaging systems and ultra-high frequency ultrasound, launched the Vevo F2 LAZR-X20 photoacoustic imaging platform. It is...

Pendopharm® and Kalvista® Collaborate to Broaden Treatment in Canada Image Credits: AInvest Announcement Pendopharm®, a part of Pharmascience Inc., has signed a distribution agreement with Kalvista Pharmaceuticals Inc., a leading biopharmaceutical company known for its development i...

Orano Med’s Expansion in Texas Announcement Orano Group’s subsidiary, Orano Med, expanded its Research and Development center to Plano, Texas (US) the new center, inaugurated to provide facilities for preclinical research and the development of radiopharmaceuticals. The center will f...

Avvio’s Certification Marked a New Phase in Global Transformation Image Credits: Avvio Medical Announcement Avvio Medical Inc., a private medical device company focused on treating kidney stone diseases, has received an ISO 13485:2016 certification for its audit, introduced by BSI (Britis...

Evaxion’s New Vaccine Program Image Credits: University of Alberta Announcement Evaxion, a techbio company leading in the development of AI-Immunology powered vaccines, has introduced a new vaccine program that is an add-on to the R&D pipeline. The company is encouraged to introduce a...

Bavarian Nordic’s First of Two Clinical Trials Image Credits: MedWatch Announcement Bavarian Nordic has initiated the first of two clinical trials to contribute to the use and approval of the MVA-BN mpox/smallpox vaccine for pregnant or breastfeeding women and 2-year-old infants. Further,...

ProFound Therapeutics, in collaboration with Novartis Image Credits: PharmaLive Which New Collaboration is Currently Streaming in the Healthcare Market? ProFound Therapeutics company focused on the human proteome to discover new medicines for various diseases, has entered into a collaboration w...

Riliprubart is Designated as an Orphan Drug in the US Image Credits: Yahoo Finance Announcement The US Food and Drug Administration approved Rilpivirine, positioning it as an orphan drug designation. Rilipubart, an investigational treatment for antibody-mediated rejection (AMR) in solid organ t...

Recordati’s Agreement with Amarin Image Credits: Fierce Pharma Announcement Recordati, an international pharmaceutical company, signed a license and supply agreement with Amarin, a company known for the treatment of cardiovascular diseases. The agreement’s purpose is to present a ma...

Verastem Oncology’s oral KRAS G12D (ON/OFF) Inhibitor in the First Patient Image Credits: Stock Titan Announcement Verastem Oncology, a biopharmaceutical company known for introducing new medicines for patients suffering from cancer-related RAS/MAPK, has announced that the first patient h...

Emery and Fortrea Pharma’s Collaboration Image Credits: Stock Titan Announcement Fortrea pharma, a known contract research organization (CRO), entered into a collaboration with Emery pharma, an analytical and bioanalytical CRO. The collaboration is initiated to deliver testing services un...

Zambon Approval and Entry into China Image Credits: Farmacia Rubino Announcement A multinational chemical pharmaceutical company, Zambon, known for its innovative care and cure, has received approval from Chinese regulatory authorities. Zambon received approval due to its vigorous local clinica...

Susan G. Komen’s Investment in Breast Cancer Research Image Credits: Susan G Komen Announcement Susan G. Komen, a known breast cancer organization, has invested $10.8 million in new research that will accelerate innovation in science and deliver effective solutions to patients suffering f...

SpaceX’s Entry in Vietnam? Image Credits: The Economic Times Announcement SpaceX, an American space technology company, has planned an expansion in Vietnam, expecting an opportunity in the healthcare market of the region that is open to adopting a digital transformation. Director of enter...

Questions on FDA Conditions Image Credits: Biospace New Regulatory Pathway At Bio2025, rare diseases leaders Yale, Ultragenyx, and Amylyx raised a few questions on the new regulatory pathways introduced by Marty Makary, an FDA commissioner. The leaders also acknowledged the efforts and addition...

GE Healthcare’s Approach to the Latest Technological Advancement Image Credits: MedTech Spectrum Announcement This year, at the Society of Nuclear Medicine and Molecular Imaging annual meeting, GE Healthcare highlighted an innovative technological solution by presenting an advanced portfo...

CHMP’s Opinion on Sarclisa Image Credits: Pharmaceutical Technology Announcement The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommendation for the approval of Sarclisa, combining dexamethasone, bortezomib, and lenalidomide for the induction...

Zivo Bioscience Partnered with Animal Health Companies to Advance Poultry Image Credits: AInvest Announcement Zivo Bioscience, Inc., an agtech R&D and biotech company known for its nutritional products and development of therapeutic has partnered with a leading animal health company to inve...

Vertex and Ono Pharmaceutical Entered into an Agreement Image Credits: Biospectrum Asia Announcement Vertex and Ono Pharmaceutical have signed a license agreement to develop and market Povetacicept in South Korea and Japan. Povetacicept is a therapeutic for various serious B-cell-mediated disea...

Taiwan's Trade Show Introduced Smart Healthcare Image Credits: Techsauce Announcement The Taiwan External Trade Development Council held a medical trade show, Medical Taiwan 2025, which attracted 316 exhibitors from 14 countries. The show highlighted advanced technology products fueled by gover...

Superlab Suisse in Geneva by 2026 Image Credits: Manufacturing Chemist Announcement Superlab Suisse has officially announced its fourth Swiss laboratory facility opening at Campus Biotech in Geneva. The new facility will be inaugurated by January 2026. The location will provide a vast space for...

Regeneron and Sanofi Receive Approval for the Medication Image Credits: FirstWord Pharma Announcement Sanofi and Regeneron Pharmaceuticals, Inc. received approval for Dupixent (dupilumab), a medication for adults suffering from bullous pemphigoid (BP). The approval of this medication was based ...

MorningStar’s Test Reached California Image Credits: AInvest Announcement MorningStar Laboratories, LLC (MSL), a global developer of precision diagnostic tests that analyze clinical needs, is proud to announce the availability of the Smartvascular Dx test (PULS Cardiac test) to patients i...

Brenus Pharma and InSphero’s Presentation Presentation InSphero, a leader in 3D cell-based assay technologies, of Swiss and Brenus pharma, a French biotech known for its next-generation excellent immunotherapies, showcased data at the European Association for Cancer Research 2025 annual co...

Immuno Cure and PharmaJet Collaborate to Advance a Vaccine Image Credits: Biospace Announcement Immuno Cure Biotech is a clinical-stage biotechnology group located in the Hong Kong Science Park, is initiating a collaboration with PharmaJet to examine the immunogenicity and safety of HIV therape...

Aptevo Therapeutics Buys Shares According to Nasdaq Rules Image Credits: NBC4 Announcement Aptevo Therapeutics Inc. is a clinical-stage biotechnology company that develops novel immune-oncology therapeutics according to its proprietary ADAPTIR-FLEX and ADAPTIR platform technologies has declared...

QIAGEN and GENCURIX Partner to Digitize the Healthcare Sector Announcement QIAGEN and GENCURIX partnered to develop oncology assays to perform on the QIAcuityDx platform. A platform popular for its excellent performance in the digital PCR system has been initiated for clinical diagnostics. GENCU...

1Elevan Shifts its Development to Fishers, Indiana Image Credits: Pharmaceutical Outsourcing Announcement 1Elevan Biopharmaceuticals company has shifted from California to Fishers, Indiana. The company has proclaimed the new headquarters in the Fishers Life Sciences and Innovation Park. The rel...

Invivoscribe’s Subsidiary Received Approval Image Credits: Invivoscribe Announcement Invivoscribe proudly announced its subsidiary’s Laboratory for Personalized Molecular Medicine (LabPMM) approval from the New York State (NYS) for the NPM1 MRD assay. The approval of the subsidiary ...

Leading Pharmaceutical Companies and their Competitive Negotiations Emerging Negotiations and Bids The acquisition of the company with the highest bid demonstrates the eagerness of the company for a merger, collaboration, and the unification and exchange of developmental progress between the two...

Standard Health and Smith+Nephew Announced a Partnership Image Credits: Orthopedic Design and Technology Announcement Smith+Nephew, a leading medical technology company, declared its partnership with Standard Health (www.standardhealth.co.uk). This partnership contributes to the development of ...

Noetik and Agenus's Collaboration for Technological Development Announcement Noetik, a global AI-driven spatial and multimodal biology, and Agenus Inc., an immune-oncology innovation, introduced a research collaboration to generate predictive biomarkers of response to Agenus. This will lead to b...

Johnson & Johnson Introduced Innovation in Various Regions Image Credits: Glance by Eyes on Eyecare Announcement Johnson & Johnson, a popular and leading company in eye health, declared an expansion of the portfolio of presbyopia-correcting intraocular lenses with the introduction of th...

Centessa Pharmaceuticals Received US FDA Clearance Image Credits: Seeking Alpha Approval Centessa Pharmaceuticals Plc, a clinical-stage pharmaceutical company, received a US Food and Drug Administration (FDA) IND clearance to initiate a phase 1 clinical study of ORX142 in healthy volunteers. Th...

Emerging Biopharma Deals Attract Analysts’ Interest in the Return of M&A Image Credits: Biopharma Dive Impact of Acquisitions and Deals The massive deals have generated analyst interest and support for activities in the second half of 2024, as the first half represents the cumulative ...

Advancements in Technology within the Pharmaceutical Industry Image Credits: Forbes Technology is an advancement in various markets and is being accepted in new and existing industries. The pharmaceutical sector is also adopting the modern era of technology and accelerating its computational pow...

HELP Therapeutics and China Resources Sanjiu’s Partnership Image Credits: Biopharma APAC Announcement HELP Therapeutics, a regenerative medicine leader, and China’s largest China Resources Sanjiu Pharmaceutical company have partnered to commercialize and co-develop the investigation...

Taipei City Government’s Partnership with Six Biotech Companies Image Credits: Biospace Announcement Taipei City Government will be announcing its partnership at the BIO International Convention (BIO2025) at the annual biotech event, which will be held Boston Convention & Exhibition C...

The EU’s Clinical Trial Market Aims to Seize the Opportunity Image Credits: Biospace Opportunity Europe’s contribution to the global clinical trial has been less over the last decade. With the change in the regulatory environment and research funding in the US, Europe could see an o...

Utilizing Technology for a Strengthened Healthcare System: Naga Malladi’s Predictive Breakthrough Analysis Image Credits: Oneindia Naga Srirama Narasimha Raviteja Malladi launched a transformative healthcare predictive analytics system capable of handling patient demands along with increas...

Chhattisgarh Signs MoU to Align Healthcare Services with Global Standards Image Credits: Times of India Chhattisgarh government signed a MoU with five powerful national and international institutions to improve the state’s healthcare system and improve overall state’s healthcare deli...

14-year-old Siddharth Develops an AI App to Detect Heart Disease in 7 Seconds Image Credits: Times of India Siddharth Nandyala, a 14-year-old boy from Frisco, United States, has developed a smartphone application which is capable of detecting in just 7 seconds. The application is named ‘Ci...

Aster DM Raises 1,900 Crore INR to Expand its Healthcare Presence Image Credits: Times of India Aster DM Healthcare, a leading Indian hospital network, raised Rs 1900 crore for expanding its hospital network across the country. The company has invested the money to establish its total bed capaci...

BioNTech and CureVac’s Purchase Agreement Image Credits: France 24 Announcement BioNTech and CureVac confirmed their entry in the official purchase agreement. Considering this agreement, BioNTech plans to acquire all shares of CureVac. CureVac, a leading clinical-stage biotech company, is...

Enterome's Funding for Clinical Development Image Credits: The Pharma Letter Investment and Funding in a Clinical Trial Enterome, a leading clinical-stage company known for its high-scale development of Oncomimics immunotherapies for cancer, has raised $19 million in fresh new financing for the...

Rivanna’s Selection for the Medtech Innovator 2025 Accelerator Cohort Image Credits: Rivanna Medical Announcement Rivanna, a leading manufacturer and medical device innovator known for its imaging-based medical solutions, proudly announced its ticket to join the Medtech Innovator 2025 acc...

Stakeholders in West Africa’s Healthcare Management, Innovation and More Image Credits: The Sun Nigeria Initiatives Stakeholders approached for collaboration, innovation, and implementation of new ideas to elevate and transform West Africa’s healthcare management. Following the decl...

Curadev’s Strategic Collaboration Image Credits: KGET.com Announcement Curadev Pharma, Inc., a leading clinical-stage biotechnology company, along with Memorial Sloan Kettering Cancer Center (MSK), a global cancer research and treatment institution novel immune-oncology therapeutics expan...

FDA Leaders Support Gene Therapy at Roundtable Conference Image Credits: Biospace Gene Therapy Gene therapy holds a prominent approach in providing treatment for genetic disorders. The gene therapy includes correcting or replacing faulty genes with healthy ones. The regional analysis states Nor...

Ambiq’s Achievement in Healthcare Semiconductor Solutions Image Credits: Ambiq Semiconductor in the Healthcare Industry Semiconductors play a significant role in healthcare by providing advancement and development in technologies and the medical devices market. It is a major component for...

Sanofi’s Smart Strategic Deals Image Credits: The Wall Street Journal What Licensing Deals Encourage Sanofi to Contribute to the Healthcare Market? Sanofi, a multinational pharmaceutical and healthcare company, has a strong approach to ROFNs in its licensing deal. Vigil, a clinical-stage ...

FUJIFILM Healthcare Europe and IBEX’s Partnership Image Credits: FugiFilm Announcement FUJIFILM Healthcare Europe, a leading digital pathology software 1, and Ibex Medical Analytics, an AI-powered cancer diagnostics company in pathology, announced a partnership. The partnership will contr...

Zimmer Biomet Introduced Technology Image Credits: ET Now Announcement Zimmer Biomet, a leading medical technology company, launched orthopedic technologies in India. The company is known for its orthopedic products and solutions. The portfolio consists of the shoulder segment, spanning the hip...

Merck’s Latest Treatment Solution Announcement Merck’s a healthcare company known for its innovative health solutions with its vaccines, biologic therapies, and more. The company is uplifting the therapy standards in healthcare by introducing ‘enlicitide decanoate.’ The e...

Sanofi and Regeneron are Strengthening their Medication Profile Image Credits: The Dermatology Digest Progress Sanofi and Regeneron pharmaceutical companies are leading the way with their popular biologic Dupixent. These companies are strengthening their eczema efficacy profile. The biologic Du...

Blue Cross's Partnership Strategy to Expand the GBA Healthcare Sector Image Credits: Insurance Asia Alliance Blue Cross (Asia Pacific) Insurance's partnership with four healthcare centers and the hospital is paving the way for the expansion of the healthcare and insurance sector. The partnershi...

Baroda BNP Paribas MF Introduced a Healthcare and Wellness Fund Image Credits: Baroda BNP Paribas Announcement Baroda BNP Paribas Asset Management India has introduced a new thematic equity scheme. A scheme is known as ‘Baroda BNP Paribas health and wellness fund. This new fund offer is r...

An Advancement in Science and Technology, a Contribution to Vietnam’s Healthcare Sector Image Credits: Business Wire Event The leading pharmaceutical industries showcased public-private partnership and innovation at the Healthcare Innovation Forum 2025, which was co-hosted in Hanoi by the...

OPTIC and Mechanica Partnership to Initiate AI-driven Venture Announcement Mechanica, a venture creation firm, to advantage Optic’s Bioptic platform innovatively. The expanded strategic collaboration intends to discover next-generation biotechnology companies. The collaborative initiative ...

Alnylam’s Goal is to Expand Medication Image Credits: Biospace Announcement Alnylam received two FDA approvals for Sanofi’s Qfitlia in hemophilia A and B, and Amvuttra in transthyretin-mediated amyloidosis. The approval is a part of Alnylam, along with other companies. Companies suc...

‘Sarepta’ Transitional Shift to Gene Therapy Development Image Credits: Biospace Platform Technology The FDA announced Sarepta Therapeutics as the FDA’s first-ever publicly documented platform technology designation. A designation for a popular vector known as ‘rAAVrh74&...

Pharmaceutical Companies Enter a New Era of Acquisitions Announcement Sanofi, a leading healthcare and pharmaceutical company, received a badge as the biggest buyer with a major contribution to rare disease specialist blueprint medicines of 9.5 billion. Whereas, Bristol-Myers Squibb offered a me...

A Drug Compilation for Small-cell Lung Cancer Image Credits: Fierce Pharma Announcement The Jazz and Roche pharmaceuticals have introduced an upgraded phase 3 data of the combined medicines Zepzelca and Tecentriq. This solution is planning to win FDA approval as a drug cocktail for small-cell l...

Image Credit: Reuters Amgen’s Imdelltra drug minimizes the risk of death by 40% in comparison to chemotherapy, mainly for small-cell lung cancer patients. The drug will help cure these patients after their worst condition, after the initial round of chemotherapy. The phase 3 trial of 509 pa...

Image Credits: Tech360.tv Announcement The US Food and Drug Administration introduced its generative AI tool, Elsa. Elsa is launched to improve and enhance operations and scientific reviews. The proven successful result of ‘Elsa’ was when one of the FDA’s applications of a pote...

Image Credits: Human Rights Watch Announcement The US President Donald Trump’s administration on Tuesday mentioned the offer of emergency abortion in every hospital. In his democratic predecessor Joe Biden’s tenure, he issued guidance that emergency abortion was discussed and asked t...

Image Credits: Reuters Announcement The US President Donald Trump’s administration on Tuesday mentioned the offer of emergency abortion in every hospital. In his democratic predecessor Joe Biden’s tenure, he issued guidance that emergency abortion was discussed and asked to consider ...

Image Credits: National Acamedy of Medicine Action The need to take action and put control on HHGE was first addressed in 2019. When a Chinese researcher, He Jiankui, Ph.D., discovered that twin girls were born from embryos with the ‘He gene’ edited using CRISPR. The group of gene ed...

Initiatives The United States has a vast number of records of donations. The country has initiated the distribution of billions of dollars to various countries. The diversified and well-established factors expand in areas such as security funding and economic development. Being the largest donor, t...

Plan Zydus Lifesciences is all set to acquire US-based Agenus Inc. and enter the vast biologics CDMO market along with two California facilities. This idea will enhance and improve Zydus Biotech's footprint. It will strengthen its place in Sri Lanka and India’s oncology market with its immune...

Announcement The Federal Express Corporation is one of the leading express transportation companies. The company proudly announced that the company’s hubs at Kansai International Airport, Japan (KIX) and Guangzhou Baiyun International Airport, China (CAN) have received the award and CEIV phar...

Initiative An effective collaboration gathered private sector partners to discover solutions. To promote solutions for cognitive health, a program was conducted on May 21-22, where two of Houston’s largest industry experts from the healthcare and energy sectors came together to highlight solu...

About Telehealth and Medicine Today is a platform for innovations, the latest research, digital health disciplines, telehealth, and applications in telemedicine. The open access to these factors accelerates the healthcare industry. The publication strengthens advancement and elevates discussion fol...

Announcement Blockchain in healthcare today is the first and single-reviewed journal representing blockchain and technologies to elevate the healthcare market. The BHTY announced the launch of its corporate advisory council. The launch is a valuable initiative to gather senior corporate leaders to ...

About The Perspectum is a popular medical technology company that provides digital technologies to support clinicians. The clinicians provide excellent care for patients suffering from multi-organ diseases, cancer, and chronic metabolic diseases with the help of technology. The company aims to impr...

Technological Advancement The known electronics manufacturer is creating smart hospital solutions with the use of NVIDIA technologies from the data center to the edge. The manufacturing of giant Foxconn will reduce the burden with the introduction of the new solution, ‘Nurabot’. The Nur...

New Technology A popular supply chain management solution provider, Tecsys Inc., launched a new technology, Tecsys IQ. It is a cloud-native intelligence layer that supports healthcare organizations by providing a unified fragmented data and AI-powered insights to financial, clinical, and operationa...

Announcement Bupa Hong Kong has announced its partnership with four leading premier healthcare providers named the GBA healthcare group, Prosper Health, Zhongshan Chen Xinghai Hospital, and Fosun Health. This partnership will give access to medical care in mainland China for residents of Hong Kong....

Date: 2nd June 2025 The Japanese subsidiary of a global cloud networking company, Engenius Networks Japan, will introduce the latest AI surveillance solutions and cloud-managed wi-fi 7 at Interop Tokyo 2025. It will be held at Makuhari Messe from 11th to 13th June. The event is a platform for digit...

Date: 2nd June 2025 Expansion Clarivate Plc is a global provider of transformative intelligence. The company announced the renewal of its multi-year partnership with CAPES. The extensional access to trusted Academia and Government Life Sciences and Healthcare data to over 400 Brazilian institution...

Date: 2nd June 2025 The Ujala Cygnus Group of Hospitals is initiating environmentally sustainable efforts by partnering with Karo Sambhav. This is India’s extended producer responsibility (EPR) and circular economy solutions provider. This strategic collaboration has introduced India’s ...

Date: 2nd June 2025 The International Healthcare Week 2025, Southeast Asia’s premier healthcare event, will be organized at the Malaysia International Trade and Exhibition Centre (MITEC), Kuala Lumpur, from 16 to 18 July. The event, initiated by Informa Markets, IHW 2025, aims to introduce in...

Date: 29th May 2025 Scope Health Inc., a leading eye-care company, announced its acquisition to support eye-care professionals. The acquisition is a valuable collaboration with the eye-care professionals is developing the finest ecosystem of products and leveraging service performance to enhance pa...

Date: 29th May 2025 Announcement Livanta, DOMA technologies, and Advanta government services are initiating to enter the transitional era of today’s healthcare market. With the ‘commence’ idea, the healthcare technology company has taken a step ahead to adopt human centered appro...

Date: 30th May 2025 Event The known provider of products and services for renal diseases, Fresenius Medical Care, showcased innovations and research at the 62nd congress of the European Renal Association. The event will be held on 4-7th June in Vienna, Austria. The event will introduce the company...

Date: 29th May 2025 Event Hong Kong’s International Medical and Healthcare 16th fair and the 5th Asia summit on global health (ASGH) were introduced by the Hongkong Kong Trade Development Council. The event was based on components of International Healthcare Week (IHW), Hong Kong. The event ...

Date: 29th May 2025 Hyperfine Inc. is the first health technology company to produce the world’s advanced FDA-cleared AI-powered portable MRI system for the brain. The ‘swoop system’ is a new technology officially introduced to the healthcare sector. This represents additional pro...

The global cosmetic chemicals market was valued at USD 24.91 billion in 2023. The market demand is anticipated to grow from USD 26.81 billion in 2024 to USD 41.7 billion by 2030, exhibiting a CAGR of 7.64% during the forecast period. The cosmetic chemicals market is the industry...